Catalyst Crew Technologies Advances Regulatory and Deployment Efforts for Telehealth Platform in Venezuela

Catalyst Crew Technologies Corp. (OTC: CCTC), a digital health and artificial intelligence technology company, has provided an update on its regulatory and initial deployment activities for its telehealth platform in Venezuela. The company is currently advancing early-stage deployment, testing, and refinement of the platform, which is accessible through its digital interface at https://latamedai.org. This platform is designed to support remote patient engagement, care coordination, and integration of AI-driven healthcare analytics within a technology-enabled healthcare environment.

In parallel, Catalyst Crew is working with the Ministerio del Poder Popular para la Salud, including the Servicio Autónomo de Contraloría Sanitaria (SACS), to obtain the required Permiso Sanitario de Funcionamiento para Plataforma Digital. The company is actively progressing through the regulatory process, addressing documentation, operational procedures, and compliance standards. Management anticipates that the permitting process may be completed in the near term, but no assurance can be provided regarding timing or outcome.

The company believes that this phase of deployment, testing, and regulatory alignment is an important step toward broader operational rollout across its target markets. Dr. Kevin Rodan Levy, CEO of Catalyst Crew Technologies, stated, “Our focus is on building a scalable telehealth platform that can operate effectively within real-world healthcare environments. We are currently advancing platform testing, refinement, and regulatory alignment as we continue to build the foundation for broader deployment across Latin America. We expect a full launch in short order and upon receiving all regulatory approvals.”

Catalyst Crew Technologies is an AI-driven healthcare technology company focused on developing scalable digital health solutions for emerging markets, with an initial emphasis on Latin America. The company is executing a strategic transition into AI-enabled healthcare, pursuing opportunities in telehealth infrastructure, remote patient monitoring, healthcare data analytics, and integrated digital care platforms. For more information, visit https://catalystcrewai.com or review the company’s filings with the U.S. Securities and Exchange Commission at www.sec.gov.

This update highlights the company’s progress in navigating regulatory hurdles and deploying technology that could improve healthcare access in underserved regions. The successful launch of the platform may serve as a model for digital health initiatives in other emerging markets, addressing critical gaps in healthcare delivery through AI and telehealth.